0000950170-24-006988.txt : 20240124
0000950170-24-006988.hdr.sgml : 20240124
20240124162048
ACCESSION NUMBER: 0000950170-24-006988
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240123
FILED AS OF DATE: 20240124
DATE AS OF CHANGE: 20240124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: de los Pinos Elisabet
CENTRAL INDEX KEY: 0001889633
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40971
FILM NUMBER: 24556744
MAIL ADDRESS:
STREET 1: C/O AURA BIOSCIENCES, INC.
STREET 2: 85 BOLTON STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aura Biosciences, Inc.
CENTRAL INDEX KEY: 0001501796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320271970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
BUSINESS PHONE: (617)500-8864
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
4
1
ownership.xml
4
X0508
4
2024-01-23
0001501796
Aura Biosciences, Inc.
AURA
0001889633
de los Pinos Elisabet
C/O AURA BIOSCIENCES, INC.
80 GUEST STREET
BOSTON
MA
01235
true
true
false
false
See Remarks
false
Common Stock
2024-01-23
4
S
false
15853
7.6415
D
161438
D
Common Stock
131412
I
By EdIP Revocable Trust
The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.6758, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.
President and Chief Executive Officer
/s/ Julie Feder, as Attorney-in-Fact
2024-01-24